FDA Inspection 818749 — Bontan Medical Corporation
The FDA completed an inspection of Bontan Medical Corporation on Feb 12, 2013 in Winter Park, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 12, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winter Park, FL (United States)